Marina Cesaretti

547 total citations
15 papers, 244 citations indexed

About

Marina Cesaretti is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Marina Cesaretti has authored 15 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 5 papers in Genetics. Recurrent topics in Marina Cesaretti's work include Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Marina Cesaretti is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Marina Cesaretti collaborates with scholars based in Italy, Brazil and Ukraine. Marina Cesaretti's co-authors include Massimo Federico, Nicola Volpi, Stefano Luminari, Luigi Marcheselli, Monica Bellei, Massimiliano Salati, Goretta Bonacorsi, Antonino Maiorana, Caterina Stelitano and Michele Spina and has published in prestigious journals such as Blood, Biomacromolecules and American Journal of Hematology.

In The Last Decade

Marina Cesaretti

14 papers receiving 239 citations

Peers

Countries citing papers authored by Marina Cesaretti

Since Specialization

Citations

This map shows the geographic impact of Marina Cesaretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Cesaretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Cesaretti more than expected).

Fields of papers citing papers by Marina Cesaretti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Cesaretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Cesaretti. The network helps show where Marina Cesaretti may publish in the future.

Co-authorship network of co-authors of Marina Cesaretti

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Cesaretti. A scholar is included among the top collaborators of Marina Cesaretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Cesaretti. Marina Cesaretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas 2019 ·American Journal of Hematology ·Francine M. Foss, Steven M. Horwitz, Monica Civallero, Monica Bellei, Luigi Marcheselli, Won Seog Kim, María Elena Cabrera, Iván Dlouhy, Arnon Nagler, Ranjana H. Advani, Emanuela Anna Pesce, Young Hyeh Ko, Silvia Montoto, Carlos Chiattone, Alison J. Moskowitz, Michele Spina, Marina Cesaretti, Irène Biasoli, Massimo Federico	38
2	The Outcome of Patients with Primary Refractory or Relapsed Peripheral T-Cell Lymphoma: Analysis of 1020 Cases Registered in the Prospective T-Cell Project 2016 ·Blood ·Monica Bellei, Francine M. Foss, Steven M. Horwitz, Luigi Marcheselli, (unknown), María Elena Cabrera, Iván Dlouhy, Arnon Nagler, Ranjana H. Advani, Emanuela Anna Pesce, Young Hyeh Ko, Virginia Martínez, Silvia Montoto, Carlos Chiattone, Alison J. Moskowitz, Michele Spina, Marina Cesaretti, Irène Biasoli, Massimo Federico	3
3	Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study 2015 ·Leukemia & lymphoma ·Emilio Iannitto, Stefano Luminari, Claudio Tripodo, Salvatrice Mancuso, Marina Cesaretti, Luigi Marcheselli, Francesco Merli, Caterina Stelitano, Angelo Michele Carella, Alberto Fragasso, (unknown), (unknown), Alessandro Pulsoni, Marco Paulli, Vito Franco, Massimo Federico	15
4	A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma 2015 ·Leukemia & lymphoma ·Stefano Luminari, Maria Goldaniga, Marina Cesaretti, Lorella Orsucci, Alessandra Tucci, Alessandro Pulsoni, Flavia Salvi, Luca Arcaini, Angelo Michele Carella, Alessandra Tedeschi, Antonio Pinto, Caterina Stelitano, Luca Baldini	8
5	EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN 2014 ·Mediterranean Journal of Hematology and Infectious Diseases ·Massimiliano Salati, Marina Cesaretti, (unknown), (unknown), Massimo Federico	30
6	Dismal outcome of t‐cell lymphoma patients failing first‐line treatment: results of a population‐based study from the Modena Cancer Registry 2014 ·Hematological Oncology ·Irène Biasoli, Marina Cesaretti, Monica Bellei, Antonino Maiorana, Goretta Bonacorsi, Micol Quaresima, Massimiliano Salati, Massimo Federico, Stefano Luminari	15
7	Bendamustine and Rituximab Combination In Untreated Indolent Non Follicular B-Cell Non-Hodgkin's Lymphomas. A Phase II Study From The Fondazione Italiana Linfomi (INFL09) 2013 ·Blood ·Stefano Luminari, Maria Goldaniga, Marina Cesaretti, Lorella Orsucci, Alessandra Tucci, Alessandro Pulsoni, Flavia Salvi, Angelo Michele Carella, Alessandra Tedeschi, Antonio Pinto, Caterina Stelitano, Daniele Vallisa, Fiorella Ilariucci, Michele Spina, Luca Arcaini, Luigi Marcheselli, Massimo Federico, Luca Baldini	2
8	NF10 Project: An International, Prospective, Observational Study Of Patients With Indolent Non-Follicular Lymphoma. Analysis Of First 215 Patients 2013 ·Blood ·Luca Arcaini, Stefano Luminari, Marina Cesaretti, Gianluca Gaïdano, Sara Rattotti, Michele Merli, Maria Giuseppina Cabras, Michele Spina, Luca Baldini, Alessandra Tedeschi, Lorella Orsucci, María Gomes da Silva, Luigi Marcheselli, (unknown), Massimo Federico	0
9	Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study 2012 ·Leukemia & lymphoma ·Angelo Michele Carella, Cármino Antônio De Souza, Stefano Luminari, Luigi Marcheselli, Annalisa Chiappella, Alice Di Rocco, Marina Cesaretti, Andrea Rossi, Luigi Rigacci, Gianluca Gaïdano, Francesco Merli, Michele Spina, Caterina Stelitano, Stefan Hohaus, Anna Maria Barbui, Benedetta Puccini, Eliana Miranda, (unknown), Massimo Federico	36
10	Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions 2012 ·Hematological Oncology ·(unknown), Irène Biasoli, Stefano Luminari, (unknown), Maurizio Musso, Matteo Dell’Olio, (unknown), Nicola Di Renzo, Marina Cesaretti, Gabriele Buda, Daniele Vallisa, Donato Mannina, Alessandro Andriani, Carlos Chiattone, Márcia Torresan Delamain, Cármino Antônio De Souza, Nelson Spector, F. Angrilli, Massimo Federico	7
11	The Outcome of T-Cell Lymphoma Patients Failing First-Line Treatment: Results of a Population Based-Study From the Modena Cancer Registry 2012 ·Blood ·Irène Biasoli, Marina Cesaretti, Stefano Luminari, Monica Bellei, Alessandra Dondi, Emanuela Anna Pesce, (unknown), Micol Quaresima, (unknown), Massimo Federico	1
12	Use of 2-[¹⁸F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy 2011 ·Leukemia & lymphoma ·Stefano Luminari, Marina Cesaretti, Chiara Tomasello, (unknown), B Bagni, Francesco Merli, (unknown), Lucìa Mangone, Annibale Versari, Francesca Re, Vincenzo De Lisi, Livia Ruffini, Stefano Ferretti, Antonio Cuneo, Massimo Federico	4
13	Incidence, clinical characteristics and survival of malignant lymphomas: a population‐based study from a cancer registry in northern Italy 2007 ·Hematological Oncology ·Stefano Luminari, Marina Cesaretti, Ivan Rashid, Caterina Mammi, Antonella Montanini, (unknown), Monica Bellei, Elsa Pennese, (unknown), Luigi Marcheselli, (unknown), Alessia Bari, Antonino Maiorana, Goretta Bonacorsi, Massimo Federico	43
14	Non-Pegylated Lyposomal Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab (R-COMP) as Initial Treatment for Patients with Splenic Marginal Zone Lymphoma (SMZL). A GISL Study 2007 ·Blood ·Emilio Iannitto, Stefano Luminari, Caterina Mammi, Viviana Minardi, Francesco Merli, F. Angrilli, Caterina Stelitano, Marina Cesaretti, Giovanni Franco, Angelo Michele Carella, (unknown)	6
15	Purification and Characterization of Heparin from the Italian ClamCallistachione 2005 ·Biomacromolecules ·(unknown), Marina Cesaretti, Nicola Volpi	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact